All articles
Obesity and Weight Loss
Prevention of Obesity and Insulin Resistance – (01-29-04)
James Bogash
Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1
Don’t feel bad–I’m new to the concept of PAI-1 being used as a marker for insulin resistance/Syndrome X as well. Research is still ongoing, but PAI-1 is a compound that increases the “stickiness” of platelets and this make be associated with (some think a causative factor in) Syndrome X. We really do need a solid, accurate method to assess presence and degree of insulin resistance. It would be nice if this compound turns out to be our answer.
Diabetes — Abstracts: Ma et al. 53 (2): 336 –
